Welcome - Head and Neck Cancer International Group

Mission of the HNCIG

The Head and Neck Intergroup aims to promote and conduct high quality clinical trials in order to improve outcomes in patients with head and neck cancers. We achieve this through international collaboration, a strong sense of common purpose, shared expertise, and mutual respect among members.

Goals of the Intergroup

Promote international cooperation
Promote clinical research
Perform studies in rare tumors
Harmonize the technical aspects of radiation delivery
Develop a credentialing process for novel radiation and surgical approaches
Promote translational research
Stimulate evidence-based medicine
Support educational activities

Clinical Trials

HNCIG clinical trials involve two or more member organizations and bear a unique HNCIG number in addition to other naming conventions.

Roster

Cooperative groups and large sites active in head and neck cancer clinical trials constitute the membership of the HNCIG.

Joining the HNCIG

The HNCIG was created as a forum for groups and large sites that contribute to phase II/III or phase III clinical trials in head and neck cancer, or which perform meta-analyses of these trials. If your group or site is interested in joining this effort, please send an email to secretariathnc@intergroup.info.

Meetings

Generally, the HNCIG alternates face-to-face board meetings alongside ICHNO and the Multidisciplinary Head Neck Cancer Symposium, but may meet alongside other widely attended meetings. All meetings also allow for dial-in participation for members not physically present. In addition to the board, the group has a number of committees, which meet independently.